I am a research associate professor in the Division of Oncological Sciences, within the Knight Cancer Institute at Oregon Health & Science University (OHSU). With a Ph.D. in Medical Genetics from the University of British Columbia and over two decades of research experience, my work focuses on identifying and targeting novel therapeutic approaches for cancer treatment, specifically in the realm of functional genomics.

As the scientific director of the Druker Lab, I oversee cutting-edge projects aimed at advancing cancer therapeutics, including roles as principal and co-investigator on several NIH-funded initiatives targeting hematological malignancies and acute myeloid leukemia. In addition to my academic role, I develop and drive collaborations between academia and industry to accelerate cancer research and drug development.

I have extensive experience coordinating and leading large, multi-institutional consortium projects focused on integrating and analyzing multi-modal datasets to identify novel therapeutic targets and biomarkers of response and resistance to therapy.

With a strong foundation in both clinical and translational research, I am dedicated to discovering innovative solutions that improve patient outcomes in oncology.